Japan Stocks Fall Sharply After Weak U.S. Jobs Data, Yen Strengthening
By Kosaku Narioka
Japanese stocks fell sharply again as disappointingly weak U.S. jobs data raised concerns about the world's biggest economy and as the yen strengthened.
The Nikkei Stock Average was recently down 5.2% at 34043.44 on Monday morning, following Friday's 5.8% loss, which was its biggest percentage-point drop since March 2020. The index was briefly down 7.1% earlier on Monday, giving up all the gains made so far in 2024 and falling 21% from its recent closing high.
U.S. jobs growth slowed sharply in July and the unemployment rate rose to its highest level since 2021, the U.S. Labor Department reported Friday. The yen strengthened against the dollar as a result.
The yen was trading at around 145.25 to the dollar on Monday in Tokyo, compared with 148.95 as of Friday's Tokyo stock-market close.
Many analysts expect the Federal Reserve to cut rates at each of its three remaining meetings this year. A handful of economists said Friday that the Fed will need to move faster if it want to improve its odds of short-circuiting an economic downturn.
Financial and exporter stocks led the declines in Tokyo on Monday. Carmaker Subaru Corp. was down 11% and Sumitomo Mitsui Financial Group was 15% lower.
Write to Kosaku Narioka at kosaku.narioka@wsj.com
(END) Dow Jones Newswires
August 04, 2024 21:29 ET (01:29 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks